GCSB 5Alternative Names: GCSB; GCSB-5; Shinbaro
Latest Information Update: 26 Aug 2013
At a glance
- Originator Green Cross
- Class Analgesics; Anti-inflammatories; Antirheumatics; Herbal medicines
- Mechanism of Action
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Marketed Osteoarthritis